Vijaya Diagnostic Centre Ltd. · NSE:VIJAYA
Vijaya Diagnostic Centre — Q2 & H1 FY22 Earnings Presentation
40 slides from Vijaya Diagnostic Centre's earnings presentation, Nov 8, 2021
Slide 1: Vijaya Diagnostic Centre – Investor Presentation Cover Letter
VIJAYA DIAGNOSTIC [wisava] | CENTRE November 8, 2021 To To Listing Department, The Corporate Relations Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED BSE LIMITED Exchange Plaza, Phiroz Jeejeebhoy Towers, 25th floor, Dalal Street, Bandra Kurla Complex, Bandra (E), MUMBAI -400 051 MUMBAI -400 001
Slide 2: Investor Presentation Q2 & H1FY22
Vijaya Diagnostic Centre Limited Investor Presentation Q2 & H1FY22
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Vijaya Diagnostic Centre Limited (the ‘Company’), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for
Slide 4: Q2 & H1 FY22 Financial Performance
Q2 & H1 FY22 Financial Performance
Slide 5: Q2 & H1FY22 – Performance Snapshot
Q2 & H1FY22 – Performance Snapshot Operational & Financial Highlights – Q2 FY22 Operational & Financial Highlights – H1 FY22 2.36 Mn 4.55 Mn Tests Tests INR 1,127.1 Mn INR 2,353.9 Mn Revenue Revenue 0.87 Mn 1.81 Mn Footfalls Footfalls INR 511.5 Mn INR 1,080.0 Mn 85 EBIDTA 85 EBIDTA Centres Centres (
Slide 6: Key Operational Highlights (1/2)
Key Operational Highlights (1/2) Annual YTD Quarterly Tests Performed (# in Million) 35% Y-o-Y 62% 4.55 2.36 2.18 7.91 6.99 7.09 1.75 2.80 FY19 FY20 FY21 H1FY21 H1FY22 Q2FY21 Q1FY22 Q2FY22 Footfalls (# in Million) 32% Y-o-Y 70% 1.81 2.79 2.63 0.94 2.38 0.87 1.06 0.66 FY19 FY20 FY21 H1FY21 H1FY22 Q2F
Slide 7: Key Operational Highlights (2/2)
Key Operational Highlights (2/2) Annual YTD Quarterly Revenue per Test (INR) COVID effect: In-line 531 646 with historical years 588 562 419 428 518 477 FY19 FY20 FY21 H1FY21 H1FY22 Q2FY21 Q1FY22 Q2FY22 Revenue per Footfall (INR) COVID effect: In-line with historical years 1,549 1,713 1,431 1,228 1,
Slide 8: Revenue – COVID and Non-COVID
Revenue – COVID and Non-COVID (INR Mn) Annual YTD Quarterly Non-COVID Revenue 22% Y-o-Y 3,388 56% 2,064 1,022 1,043 3,232 2,926 852 1,326 FY19 FY20 FY21 H1FY21 H1FY22 Q2FY21 Q1FY22 Q2FY22 COVID Revenue* % of Revenue 14.2% 19.6% 12.3% 24.7% 16.7% 7.5% 535 280 70% Y-o-Y 323 205 290 84 0 0 FY19 FY20 FY
Slide 9: Key Financial Highlights (1/2)
Key Financial Highlights (1/2) (INR Mn) Annual YTD Quarterly Revenue from Operations 3,767 43% 2,354 1,131 1,227 1,127 3,388 1,649 2,926 FY19 FY20 FY21 H1FY21 H1FY22 Q2FY21 Q1FY22 Q2FY22 EBITDA & EBITDA Margin (%) 37.0% 39.1% 44.1% 39.5% 45.9% 45.3% 46.3% 45.4% 1,660 66% 513 569 511 1,326 1,080 1,08
Slide 10: Key Financial Highlights (2/2)
Key Financial Highlights (2/2) Annual YTD Cash Flow from Operations / EBITDA (%) 84% 80% 78% 84% 89% FY19 FY20 FY21 H1FY21 H1FY22 Cash & Cash Equivalents (INR Mn) 2,277 1,729 2,286 1,860 1,215 FY19 FY20 FY21 H1FY21 H1FY22 Working Capital Days FY19 FY20 FY21 H1FY21 H1FY22 -13 -12 -13 -11 -16 Cash & C
Slide 11: Consolidated Profit & Loss Account – Quarterly & Half Yearly
Consolidated Profit & Loss Account – Quarterly & Half Yearly (INR Mn) Particulars Q2FY22 Q2FY21 Y-o-Y Q1FY22 Q-o-Q H1FY22 H1FY21 Y-o-Y Revenue from operations 1,127.1 1,131.4 0% 1,226.9 -8% 2,353.9 1,648.5 43% Cost of materials consumed 162.4 193.0 -16% 210.8 -23% 373.2 268.5 39% Employee benefits e
Slide 12: Consolidated Balance Sheet
Consolidated Balance Sheet (INR Mn) Assets Sep-21 Mar-21 EQUITY AND LIABILITIES Sep-21 Mar-21 NON-CURRENT ASSETS 3,954 3,022 EQUITY 4,212 3,592 Property, plant and equipment 1,660 1,358 Equity share capital 102 45 Capital work-in-progress 159 82 Other equity 4,101 3,545 Goodwill 53 53 Minority Inter
Slide 13: Company Overview
VIJAYA fc 5) DIAGNOSTIC [WISAYA] CENTRE Company Overview The Pioneers in Diagnostic Medicare.
Slide 14: Vijaya at a Glance
Vijaya at a Glance Vijaya Diagnostic Centre Limited is the largest integrated diagnostic chain in South India with 85 state-of-the-art centres spread across 14 cities 40+ 85 Mission Years of Experience Centres Quality Experience in delivering Quality Diagnostic Service State-of-the-art Facilities wi
Slide 15: Our Journey
Our Journey Awarded Brand of the year in diagnostic One of the earliest private diagnostic Vijaya Diagnostic Centre Recognized as one of the Best Imaging services by The CEO Magazine and service providers to be approved for incorporated in Hyderabad centres in Hyderabad by The Week Telangana Healthc
Slide 16: At the Forefront of Introducing New Technologies
At the Forefront of Introducing New Technologies Ultrasound & Nuclear Medicine Fourth Generation 1981 Echocardiography 1986 1993 CT Scan 1994 Offer Mammography facility Hawkeye Gamma Automated Microbiology Real Time RT-PCR Assays 2006 2003 Culture 2000 1999 Bone Densitometry Camera with SPECT & Flow
Slide 17: Our Pillars of Strength
Our Pillars of Strength 1 One of the leading players in India’s high growth diagnostics market 2 Integrated diagnostics provider offering one-stop solution 3 High brand recall driving customer stickiness 4 Robust technical capabilities and state-of-the-art technology 5 Experienced Board and strong m
Slide 18: Indian Diagnostics Market expected to Grow at a Healthy Trajectory
Indian Diagnostics Market expected to Grow at a Healthy Trajectory Indian Diagnostics Market Segment-wise breakup of Indian Diagnostic Market (INR Bn) Radiology Pathology 980 980 +13% +13% FY23E CAGR CAGR 275 - 285 43% - 44% 684 684 FY20 +13% - 14% 190 - 195 CAGR 43% 472 472 +14% CAGR South India 41
Slide 19: One of the leading players in India's high growth diagnostics market
One of the leading players in India’s high growth diagnostics market Telangana and Andhra Pradesh Market Size Vijaya’s Core Geographies Telangana and Andhra (INR Bn) Dominant Position in Pradesh (44 - 46% of South Telangana & India) Andhra Pradesh +14% 120 -130 Karimnagar CAGR Nizamabad 87 Hanamkond
Slide 20: Integrated Diagnostic service provider with extensive network
Integrated Diagnostic service provider with extensive network… National Reference Lab Vijaya Diagnostic Centre Flagship Centre #1 #1 Reference Lab Customers Hubs #21 Samples #10 Customer (Walk-in) Home Collection B2B Hospitals & Labs Sample Flow Patient Flow Diagnostic Centres / Spokes #63 Flagship
Slide 21: One-Stop Solutions for Pathology & Radiology
…offering One-Stop Solutions for Pathology & Radiology Complete Range of Diagnostic services under One Roof Comprehensive and high quality integrated diagnostic services through our operational network 20
Slide 22: High brand recall driving customer stickiness
High brand recall driving customer stickiness Customer Centric Approach Quality Diagnostic Services B2C Revenue 90.0% 93.0% 92.0% Higher brand recall FY19 FY20 FY21 High share of walk-in customers Operational Metrics (INR) Sticky individual customer 1,431 1,228 1,214 “For excellence in Quality and “
Slide 23: Robust Technical Capabilities with State-of-the-art IT Infrastructure
Robust Technical Capabilities with State-of-the-art IT Infrastructure 5 Advanced Software to Manage Clinical Data 16 CT Machines PET CT / Gamma machines 18 198 Fully Integrated Radiology Advance Laboratory MRI Machines Radiologists, Lab Doctors & Information Systems (RIS) and Information Management
Slide 24: Experienced Board of Directors
Experienced Board of Directors Dr. S Surendranath Reddy - Executive Chairman Dr. D Nageshwar Reddy - Non-executive, Independent Director Founder of Vijaya with 40+ years of experience in building Vijaya as South India’s largest integrated diagnostic chain Chairman of Asian Institute of Gastroent
Slide 25: Strong Management Team
Strong Management Team Dr. S. Surendranath Reddy Mr. Sunil Chandra Kondapally Ms. Suprita Reddy Mr. Narasimha Raju K.A Ms. Anusha Kanumuru Executive Chairman Executive Director Chief Executive Officer Chief Financial Officer Company Secretary & Compliance Officer 40+ years of experience in With
Slide 26: Awards & Accolades
Awards & Accolades One of the Best Healthcare Leading Diagnostics with Leading Diagnostic Chain of the India’s Greatest Brands 2020-21 India’s Greatest Leaders 2020-21 Brands 2021 Excellence in Quality & Safety Year Pride of Nation Ms. Suprita Reddy - CEO 2021 2021 2021 2021 2021 Presented by Presen
Slide 27: Shareholding Pattern
Shareholding Pattern Others Shareholding Pattern as of 30th September 2021 FII’s 6.0% Category % Holding 13.7% Kedaara Capital* 10.0% Axis Mutual Fund^ 6.4% Promoter & Promoter 15.5% Fidelity Group#^ 3.3% 54.8% group Aberdeen Standard Investments^ 2.7% 10.0% Mirae Asset Mutual Fund^ 1.9% DII’s Nippo
Slide 28: Strategy Going Forward
VIJAYA fc 5) DIAGNOSTIC [WISAYA] CENTRE Strategy Going Forward
Slide 29: Deepen Footprint in our Core Markets - Telangana & Andhra Pradesh
Deepen Footprint in our Core Markets - Telangana & Andhra Pradesh Leveraging Existing Presence Given under-penetration of diagnostic market, we will continue to focus on Opening additional diagnostic centres through owned & franchisee model Nizamabad Karimnagar Expanding network through setting up s
Slide 30: Continued Focus on Providing Customer Centric Services and Offerings
Continued Focus on Providing Customer Centric Services and Offerings Preventive and Wellness Testing to Boost Demand for Diagnostics FY20E Industry Size FY23P CAGR: ~20% 101-108 61-68 Rest of the Wellness & Rest of the Wellness & market Preventive market Preventive 90% 9% - 10% 89% 11% FY20 FY23 Key
Slide 31: Expand in Adjacent Geographies & East India
Expand in Adjacent Geographies & East India Network (H1FY22) East India Strategy Expand presence in East India given growing demand Replicate our successful hub and spokes model in East India Established a hub in Kolkata and plan is to set up additional diagnostic centres South India Strategy
Slide 32: Financial & Operational Highlights
Financial & Operational Highlights
Slide 33: Robust Operational Metrics
Robust Operational Metrics Diagnostic Centre (Nos) Footfalls (Mn) Tests Performed (Mn) Impact of Covid- 19 on Walk-in Impact of 80 Customers Covid-19 73 2.79 2.63 7.91 61 2.38 6.99 7.09 FY19 FY20 FY21 FY19 FY20 FY21 FY19 FY20 FY21 Test per Footfall (Nos) Revenue per Test (INR) Revenue per Footfall (
Slide 34: Consistent Financial Performance
Consistent Financial Performance (INR Mn) Revenue EBIDTA PAT CAGR:13% 3,767 CAGR:24% 1,660 843 CAGR:36% 3,388 2,926 1,326 625 1,081 459 FY19 FY20 FY21 FY19 FY20 FY21 FY19 FY20 FY21 EBIDTA Margin (%) PAT Margin (%) 710 bps 670 bps 44.1% 22.4% 37.0% 39.1% 18.5% 15.7% FY19 FY20 FY21 FY19 FY20 FY21 33
Slide 35: Sustainable Cash Generation & Increasing Return Ratios
Sustainable Cash Generation & Increasing Return Ratios Cash & Cash Equivalents CFO / EBIDTA (%) (INR Mn) 2,277 84% 80% 78% 1,729 1,215 FY19 FY20 FY21 FY19 FY20 FY21 RoCE Pre-Cash (%) RoE (%) 43% 22% 23% 23% 33% 30% FY19 FY20 FY21 FY19 FY20 FY21 ROCE (Pre-cash): PBIT ex Other income / (Total Assets –
Slide 36: Annexure
VIJAYA fc 5) DIAGNOSTIC [WISAYA] CENTRE Annexure The Pioneers in Diagnostic Medicare.
Slide 37: Consolidated Profit & Loss Account
Consolidated Profit & Loss Account (INR Mn) Particulars FY21 FY20 FY19 Revenue from operations 3,767 3,388 2,926 Cost of materials consumed 571 439 405 Employee benefits expense 574 624 539 Other expenses 962 999 901 EBITDA 1,660 1,326 1,081 EBITDA % 44.1% 39.1% 36.9% Other income 118 154 104 Deprec
Slide 38: Consolidated Balance Sheet
Consolidated Balance Sheet (INR Mn) Assets Mar-21 Mar-20 Mar-19 EQUITY AND LIABILITIES Mar-21 Mar-20 Mar-19 NON-CURRENT ASSETS 3,021 2,959 2,689 EQUITY 3592 2741 2069 Property, plant and equipment 1,358 1,398 1,437 Equity share capital 45 45 45 Capital work-in-progress 82 93 27 Instruments entirely
Slide 39: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement (INR Mn) Particulars Mar-21 Mar-20 Mar-19 Cash Flow from Operating Activities Profit before Tax 1,121 834 653 Adjustment for Non-Operating Items 534 492 431 Operating Profit before Working Capital Changes 1,655 1,326 1,084 Changes in Working Capital -46 -32 8 Cash Ge
Slide 40: Thank You
THANK YOU Company Investor Relations Advisors Vijaya Diagnostic Centre Limited (VDCL) Orient Capital (a division of Link Group) Mr. Krishna Kiran – Investor Relations Ms. Neha Shroff: +91 77380 73466 +91 90597 00749 neha.shroff@linkintime.co.in krishnakiran@vijayadiagnostic.in ir@vijayadiagnostic.in
Vijaya Diagnostic Centre — Q2 & H1 FY22 Earnings Presentation on 6ix